Inhibition of DNA-PK activity by phosphorothioate oligonucleotides

硫代磷酸酯寡核苷酸对 DNA-PK 活性的抑制

基本信息

  • 批准号:
    12470184
  • 负责人:
  • 金额:
    $ 8.38万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2002
  • 项目状态:
    已结题

项目摘要

Phosphorothioate oligonudeotides and suramin bind to heparin binding proteins including DNA polymerases, and inhibit their functions. In the present study, we report inhibition of DNA-dependent protein kinase (DNA-PK) activity by phosphorothioate oiigonucleotides, suramin and heparin. Inhibitory effect of phosphorothioate oligonudeotides on DNA-PK activity was increased with length and reached a plateau at 36-mer. The base composition of phosphorothioate digonucleotides did not affect the inhibitory effect The inhibitory effect by phosphorothioate oligodeoxycytidine 36-mer can be about 200-fold greater than that by the phosphodiester oligodeoxycytidine 36-mer. The inhibitory effect was also observed with purified DNA-PK, which suggests direct interaction between DNA-PK and phosphorothioate oligonucleotides. DNA-PK will have different binding positions for double-stranded DNA and phosphorothioate oligodeoxycytidine 36-mer because they were not competitive in DNA-PK activation. Suramin and heparin inhibited DNA-PK activity with IC_<50> of 1.7 μM and 0.27 μg/ml respectively. DNA-PK activities and DNA double-stranded breaks (DSBs) repair in cultured cells were significantly suppressed by the treatment with suramin in vivo. Our present observations suggest that suramin mav possibly result in sensitization of cells to ionizing radiation bv inactivation of DNA-PK and the impairment of DSBs repair.
硫代寡核苷酸和苏拉明与包括DNA聚合酶在内的肝素结合蛋白结合,并抑制其功能。在本研究中,我们报道了硫代寡核苷酸、苏拉明和肝素对DNA依赖蛋白激酶(DNA-PK)活性的抑制作用。硫代寡核苷酸对DNA-PK活性的抑制作用随时间的延长而增强,在36-mer时达到平台期。硫代双核苷酸的碱基组成不影响抑制作用,硫代寡脱氧胞苷36-聚体的抑制作用约为磷酸二酯脱氧胞苷36-聚体的200倍。纯化的DNA-PK也有抑制作用,提示DNA-PK与硫代寡核苷酸有直接的相互作用。DNA-PK与双链DNA和硫代寡聚脱氧胞苷36-聚体的结合位置不同,因为它们在DNA-PK的激活过程中不具有竞争性。苏拉明和肝素抑制DNA-PK活性的IC_(50)和IC_(50)分别为1.7μM和0.27μg/ml。苏拉明可显著抑制培养细胞的DNA-PK活性和DNA双链断裂(DSB)修复。我们目前的观察表明,苏拉明MAV可能通过使DNA-PK失活和DSBs修复受损而导致细胞对电离辐射的敏化。

项目成果

期刊论文数量(44)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yoshida, M.: "Roles of DNA-dependent protein kinase and ATM in cell-cycle dependent radiation sensitivity in human cells"International Journal of Radiation Biology. 78. 503-512 (2002)
Yoshida, M.:“DNA 依赖性蛋白激酶和 ATM 在人类细胞细胞周期依赖性辐射敏感性中的作用”国际放射生物学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Enomoto, A.: "Decreased c-Myc expression involved in X-ray-induced apoptotic cell death of human T-cell leukemia cell line MOLT-4"International Journal of Radiation Biology. in press.
Enomoto, A.:“c-Myc 表达降低参与 X 射线诱导的人 T 细胞白血病细胞系 MOLT-4 的细胞凋亡”国际放射生物学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tomita, M.: "Wortmannin enhanced X-ray-induced apoptotic cell death through JNK/SAPK activation in human T-cell leukemia MOLT-4 cells"Radiation Research. in press.
Tomita, M.:“渥曼青通过人 T 细胞白血病 MOLT-4 细胞中的 JNK/SAPK 激活增强 X 射线诱导的细胞凋亡”辐射研究。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hosoi, Y.: "Phosphorothioate oligonucleotides, suramin and heparin inhibit DNA-dependent protein kinase activity"British Journal of Cancer. (in press).
Hosoi, Y.:“硫代磷酸酯寡核苷酸、苏拉明和肝素抑制 DNA 依赖性蛋白激酶活性”英国癌症杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Enomoto, A.: "Decreased c-Myc expression involved in X-ray-induced apoptotic cell death of human T-cell leukemia cell line MOLT-4"International Journal of Radiation Biology. (in press).
Enomoto, A.:“c-Myc 表达降低参与 X 射线诱导的人 T 细胞白血病细胞系 MOLT-4 的细胞凋亡”国际放射生物学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HOSOI Yoshio其他文献

HOSOI Yoshio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HOSOI Yoshio', 18)}}的其他基金

Radiosensitization of radioresistant cancer stem cells by inhibition of ATM
通过抑制 ATM 实现抗辐射癌症干细胞的放射增敏
  • 批准号:
    23659588
  • 财政年份:
    2011
  • 资助金额:
    $ 8.38万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Radiation sensitization though regulation of transcriptional factor Sp1
通过转录因子 Sp1 的调节实现放射增敏
  • 批准号:
    18390330
  • 财政年份:
    2006
  • 资助金额:
    $ 8.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Inhibition of DNA-PK activity and radio-sensitization induced by single strand DNA
单链 DNA 诱导的 DNA-PK 活性抑制和放射增敏作用
  • 批准号:
    15390357
  • 财政年份:
    2003
  • 资助金额:
    $ 8.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Effect of a phosphatidylinositol 3-kinase inhibitor wortmannin on radiation and bleomycin sensitivities.
磷脂酰肌醇 3-激酶抑制剂渥曼青霉素对辐射和博莱霉素敏感性的影响。
  • 批准号:
    09670911
  • 财政年份:
    1997
  • 资助金额:
    $ 8.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Natural products inhibitors targeting homology-directed DNA repair for cancer therapy
针对癌症治疗的同源定向 DNA 修复的天然产物抑制剂
  • 批准号:
    10651048
  • 财政年份:
    2023
  • 资助金额:
    $ 8.38万
  • 项目类别:
Novel therapeutic strategies using histone modifications and DNA repair pathways in refractory gynecological cancer
利用组蛋白修饰和 DNA 修复途径治疗难治性妇科癌症的新治疗策略
  • 批准号:
    23K08882
  • 财政年份:
    2023
  • 资助金额:
    $ 8.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of the predictability of lung cancer using DNA Repair functional assays and cryopreserved blood samples of the PLCO prospective cohort
使用 DNA 修复功能测定和 PLCO 前瞻性队列冷冻保存的血液样本分析肺癌的可预测性
  • 批准号:
    10641094
  • 财政年份:
    2023
  • 资助金额:
    $ 8.38万
  • 项目类别:
DNA repair dysfunction in cancer induced by altered BRCA2 localization
BRCA2 定位改变引起的癌症 DNA 修复功能障碍
  • 批准号:
    10739521
  • 财政年份:
    2023
  • 资助金额:
    $ 8.38万
  • 项目类别:
Elucidation of regulatory mechanisms for cancer therapy resistance using DNA repair properties
利用 DNA 修复特性阐明癌症治疗耐药性的调节机制
  • 批准号:
    23H03541
  • 财政年份:
    2023
  • 资助金额:
    $ 8.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Targeting DNA repair mechanisms by nanoparticles of RNA and radiosensitizer for enhancing treatment of brain metastases of breast cancer
通过 RNA 纳米颗粒和放射增敏剂靶向 DNA 修复机制,增强乳腺癌脑转移的治疗
  • 批准号:
    488264
  • 财政年份:
    2023
  • 资助金额:
    $ 8.38万
  • 项目类别:
    Operating Grants
Mechanism of Transcription-coupled DNA Repair and its Impact on Cancer Mutations
转录偶联DNA修复机制及其对癌症突变的影响
  • 批准号:
    10660150
  • 财政年份:
    2023
  • 资助金额:
    $ 8.38万
  • 项目类别:
PG545 synergizes with PARP inhibitors in ovarian cancer to disrupt DNA repair through modulation of DEK-RAD51 axis
PG545 与卵巢癌中的 PARP 抑制剂协同作用,通过调节 DEK-RAD51 轴破坏 DNA 修复
  • 批准号:
    10553686
  • 财政年份:
    2022
  • 资助金额:
    $ 8.38万
  • 项目类别:
Validating novel DNA repair deficient cancer therapy targets and small molecule compounds
验证新型 DNA 修复缺陷癌症治疗靶点和小分子化合物
  • 批准号:
    10546636
  • 财政年份:
    2022
  • 资助金额:
    $ 8.38万
  • 项目类别:
Understanding and targeting RNA/transcription-dependent DNA repair in cancer cells
了解和靶向癌细胞中的 RNA/转录依赖性 DNA 修复
  • 批准号:
    10810914
  • 财政年份:
    2022
  • 资助金额:
    $ 8.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了